Biotech’s top money raisers: 2024

... GLP-1 drugs—including an injectable GLP-1/GIP receptor dual agonist and an oral small-molecule GLP-1 receptor agonist, both clinical-stage ...

... GLP-1 drugs—including an injectable GLP-1/GIP receptor dual agonist and an oral small-molecule GLP-1 receptor agonist, both clinical-stage ...

Dr Priya Jaisinghani discusses the benefits of GLP-1 therapy beyond glycemic control and weight management.

Select Healthy Choice frozen meal packages get a makeover with an "On Target" nutritional badge to target the 15.5 million US adults taking GLP-1 ...

... CU Researcher Studying Effects of GLP-1 Drugs on Alcohol Addiction. by Greg Glasgow | Feb 7, 2025 ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 ...

Among women, it altered levels of GLP-1, reducing satiety, meaning women felt less full after eating. So what foods should people eat if they want ...

... semaglutide shortage had been resolved. Semaglutide is the active ingredient in weight loss meds like Ozempic and Wegovy, and compounding is legal ...

Many people who have tried to lose weight by cutting calories are familiar with this frustrating reality: At some point, the body stops shedding pounds. It senses the reduced calorie intake and responds by slowing down metabolism, causing it to burn fewer calories than before the diet.

Semaglutide, a GLP-1 receptor agonist initially approved for type 2 diabetes and later for weight management, is now showing potential in treating ...

Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used: along with diet and exercise to improve blood ...